News | April 20, 2026
Eli Lilly flags counterfeit Mounjaro seizure in Gurugram
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
Subscribe To Our Newsletter & Stay Updated
